Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tardive dyskinesia: current clinical issues.

R E Burke

    Neurology
    |October 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Tardive dyskinesia (TD) involves involuntary movements from antipsychotic use. Understanding TD subtypes and risk factors is crucial for prevention and management, as current treatments are not universally effective.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Impact of Frailty on Gait Speed Improvements in Home Health after Hospital Discharge: Secondary Analysis of Two Randomized Controlled Trials.

    The Journal of frailty & aging·2024
    Same author

    Quantitative morphological comparison of axon-targeting strategies for gene therapies directed to the nigro-striatal projection.

    Gene therapy·2013
    Same author

    Animal models of induced apoptotic death in the substantia nigra.

    Methods in molecular medicine·2011
    Same author

    Apoptotic morphology in phenotypically defined dopaminergic neurons of the substantia nigra.

    Methods in molecular medicine·2011
    Same author

    Naturally Occurring Cell Death during Postnatal Development of the Substantia Nigra Pars Compacta of Rat.

    Molecular and cellular neurosciences·2009
    Same author

    GDNF as a candidate striatal target-derived neurotrophic factor for the development of substantia nigra dopamine neurons.

    Journal of neural transmission. Supplementum·2006
    Same journal

    Factors Associated With Disability Improvement and Worsening Independent of Attacks in Patients With AQP4-IgG+ NMOSD and MOGAD: A Multicenter Cohort Study.

    Neurology·2026
    Same journal

    Cost-Effectiveness of Intracranial Aneurysm Screening: A Systematic Review.

    Neurology·2026
    Same journal

    Rare Eating Epilepsy: Co-Occurrence of Focal Cortical Dysplasia and Gray Matter Heterotopia.

    Neurology·2026
    Same journal

    Spatiotemporal Associations Between Cortical Microinfarcts and Cortical Superficial Siderosis in Cerebral Amyloid Angiopathy.

    Neurology·2026
    Same journal

    Blood-Brain Barrier Disruption Before Interhospital Transfer for Thrombectomy and Clinical Outcome.

    Neurology·2026
    Same journal

    At Death's Door: Cytosolic Dopamine in Patients With Parkinson Disease.

    Neurology·2026
    See all related articles

    Area of Science:

    • Neuroscience
    • Psychiatry
    • Pharmacology

    Background:

    • Tardive dyskinesia (TD) is characterized by persistent involuntary movements resulting from antipsychotic drug treatment.
    • Accurate psychiatric diagnosis and judicious use of antipsychotics are key for TD prevention.
    • Limited knowledge exists regarding antipsychotic drug regimens influencing TD risk.

    Purpose of the Study:

    • To explore the potential existence of clinical subtypes of Tardive dyskinesia.
    • To differentiate Tardive dystonia and persistent motor restlessness from typical oral choreic TD.
    • To understand the phenomenology, epidemiology, and clinical pharmacology of potential TD subtypes.

    Main Methods:

    • Phenomenological analysis of TD presentations.
    • Epidemiological data review.

    Related Experiment Videos

  • Clinical pharmacology assessment of different TD presentations.

    • Main Results:

    • Tardive dystonia presents differently from oral choreic TD in phenomenology, epidemiology, and pharmacology.
    • Persistent motor restlessness appears distinct in phenomenology and epidemiology.
    • While typical oral TD may not be disabling, Tardive dystonia and persistent motor restlessness can be.

    Conclusions:

    • TD may spontaneously remit more often than previously thought, but often remains persistent.
    • Distinct clinical subtypes of TD, such as Tardive dystonia and persistent motor restlessness, may exist.
    • No universally effective therapy is currently available for Tardive dyskinesia.